A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma

PURPOSE: To observe the efficacy and safety of anlotinib as a first-line treatment for patients with advanced hepatocellular carcinoma (aHCC) in a real-word environment, explore the optimal treatment regimen for patients with aHCC using anlotinib as a first-line treatment. PATIENTS AND METHODS: Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingqing, Su, Tong, Zhang, Xu, Pan, Yanfeng, Ma, Shengli, Zhang, Lu, Zhang, Xianqiang, Gao, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580834/
https://www.ncbi.nlm.nih.gov/pubmed/36275784
http://dx.doi.org/10.2147/CMAR.S379911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580834/
https://www.ncbi.nlm.nih.gov/pubmed/36275784
http://dx.doi.org/10.2147/CMAR.S379911

Ejemplares similares